ToxCast Endpoints
For more information regarding the endpoints, refer to the 'ToxCast Endpoints' file on the DOWNLOAD page.

ToxCast Endpoints for intended target type: RNA
Assay NameTissueTarget Gene IDTarget HGNC SymbolTarget UniProt IDResponseAC50 value
LTEA_HepaRG_CYP1A1Liver1543CYP1A1P04798Activatory50.00 μM
LTEA_HepaRG_CYP2B6Liver1555CYP2B6P20813Activatory31.86 μM

ToxCast Endpoints for intended target type: Protein
Assay NameTissueTarget Gene IDTarget HGNC SymbolTarget UniProt IDResponseAC50 value
ATG_ERE_CISLiver2099ESR1P03372Activatory100.00 μM
ATG_PXRE_CISLiver8856NR1I2O75469Activatory72.40 μM
ATG_ERa_TRANSLiver2099ESR1P03372Gain35.38 μM
ATG_RXRb_TRANSLiver6257RXRBP28702Gain61.71 μM
BSK_3C_TissueFactorVascular2152F3P13726Inhibitory4.37 μM
TOX21_p450_CYP1A2_Antagonist1544CYP1A2P05177Loss10.19 μM
TOX21_p450_CYP2C9_Antagonist1559CYP2C9P11712Loss27.99 μM
TOX21_p450_CYP1A2_Antagonist1544CYP1A2P05177Loss10.11 μM

No ToxCast endpoints for intended target type: Molecular Messengers

ToxCast Endpoints for intended target type: Pathway
Assay NameTissueTarget Gene IDTarget HGNC SymbolTarget UniProt IDResponseAC50 value
TOX21_ARE_BLA_Agonist_ratioLiver4780NFE2L2Q16236Gain71.41 μM
TOX21_p53_BLA_p5_ch2IntestinalGain86.48 μM
TOX21_p53_BLA_p5_ratioIntestinal7157TP53P04637Gain87.29 μM

ToxCast Endpoints for intended target type: Cellular
Assay NameTissueResponseAC50 value
TOX21_RT_HEK293_FLO_24hr_viabilityKidneyGain31.73 μM
TOX21_RT_HEK293_FLO_32hr_viabilityKidneyGain38.80 μM
TOX21_RT_HEK293_FLO_40hr_viabilityKidneyGain38.80 μM
TOX21_RT_HEK293_FLO_40hr_viabilityKidneyGain54.48 μM

ToxCast Endpoints for intended target type: Extracellular
Assay NameTissueResponseAC50 value
TAMU_PeakParms_SingleDonor1434_ChronotropyHeartInhibitory50.00 μM
DISCLAIMER

TICToK is a database of tattoo ink chemicals compiled from different regulatory resources. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on tattoo ink chemicals is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.